To access this element change to forms mode OFF
Grant Award View - GA57067
Preventing cognitive decline with metformin: a randomised controlled...
GA ID:
GA57067
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Jun-2019
Publish Date:
8-Aug-2019
Category:
Medical Research
Grant Term:
1-Aug-2019 to 31-Jul-2024
Value (AUD):
$1,998,024.60
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Boosting Dementia Research Grants
Grant Activity:
Preventing cognitive decline with metformin: a randomised controlled trial.
Purpose:
Metformin is a safe, cheap medication with 60-y proven safety. It is used first in people with type 2 diabetes. In the last decade, there is building evidence of benefit in cancer, heart disease, weight management. Most recently, it has been shown to slow decline in cognition. This study will examine whether metformin can slow or stop cognitive decline and structural brain changes in people at risk of dementia and holds the potential to repurpose a cheap safe medication for dementia prevention
GO ID:
GO Title:
Boosting Dementia Research Grants Scheme: Priority Round 5
Internal Reference ID:
GNT1171665
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Garvan Institute of Medical Research
Recipient ABN:
62 330 391 937
Grant Recipient Location
Suburb:
Darlinghurst
Town/City:
Darlinghurst
Postcode:
2010
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA